Large PDD (PDD) ADS option holdings reported by SVP of Engineering
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
PDD Holdings Inc. senior vice president of engineering Wang Mi filed an initial statement of beneficial ownership, detailing multiple option awards over the company’s ADSs. The holdings include options over 322,350 ADSs and several smaller grants, each option giving the right to receive one ADS at an exercise price of US$0.026.
Some options are already exercisable, while others vest in scheduled installments between 2026 and 2032, with expirations running from 2039 through 2045. Each ADS represents four Class A ordinary shares, so these awards provide long-term equity exposure tied to the company’s performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Wang Mi
Role
SVP of Engineering
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
Holdings After Transaction:
Options (right to buy) — 322,350 shares (Direct)
Footnotes (1)
- These options are all exercisable as of the filing date. The expiration dates for 286,100 options, 18,750 options and 17,500 options are February 28, 2039, August 31, 2039 and March 31, 2040, respectively. Each American depositary share ("ADS") of the Issuer represents four (4) Class A ordinary shares. Each option represents the right to receive, at settlement after exercise, one American Depositary Share ("ADS") of the Issuer, and has an exercise price of US$0.026. These options will become exercisable on September 1, 2026. The expiration date for these options is August 31, 2039. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options. Half of these options will become exercisable on each of the following dates: April 1, 2026 and April 1, 2027. The expiration date for these options is March 31, 2040. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options. One-third of these options will become exercisable on each of the following dates: April 1, 2026, April 1, 2027 and April 1, 2028. The expiration date for these options is March 31, 2041. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options. One-fourth of these options will become exercisable on each of the following dates: April 1, 2026, April 1, 2027, April 1, 2028 and April 1, 2029. The expiration date for these options is March 31, 2042. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options. One-fourth of these options will become exercisable on each of the following dates: June 1, 2027, June 1, 2028, June 1, 2029 and June 1, 2030. The expiration date for these options is May 31, 2043. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options. One-fourth of these options will become exercisable on each of the following dates: May 1, 2028, May 1, 2029, May 1, 2030 and May 1, 2031. The expiration date for these options is April 30, 2044. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options. One-fourth of these options will become exercisable on each of the following dates: May 1, 2029, May 1, 2030, May 1, 2031 and May 1, 2032. The expiration date for these options is April 30, 2045. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options. One-fourth of these options will become exercisable on each of the following dates: December 1, 2029, December 1, 2030, December 1, 2031 and December 1, 2032. The expiration date for these options is November 30, 2045. The date exercisable has taken into account the three-year lock-up period included as a term in the grant of options.
FAQ
What does the PDD Form 3 filing by SVP of Engineering Wang Mi show?
The Form 3 shows that SVP of Engineering Wang Mi holds multiple option awards over PDD ADSs. These options provide the right to acquire ADSs over many years, reflecting existing equity-based compensation rather than new open‑market share purchases or sales.
How many PDD ADS options does Wang Mi report in this Form 3?
The filing reports several option grants, including one over 322,350 ADSs and additional grants over smaller blocks such as 100,000, 40,000 and 37,500 ADSs. Each option award is listed with its own vesting schedule and long-dated expiration, indicating sizeable derivative exposure.
What is the exercise price of Wang Mi’s PDD options disclosed in the Form 3?
Each option carries an exercise price of US$0.026 per ADS. This means that, upon vesting and exercise, Wang Mi can acquire one American depositary share of PDD for US$0.026, subject to the terms and lock‑up conditions described in the awards’ footnotes.
When do the PDD options reported by Wang Mi vest and expire?
Some options are already exercisable as of the filing date, with others vesting in tranches between 2026 and 2032. Expiration dates range from 2039 to 2045, providing long-term potential ownership if vesting conditions and lock‑up requirements are met.